Real-world screening for interstitial lung disease in rheumatoid arthritis: the value of spirometry, DLCO, and clinical risk factors
Authors
Oana-Georgiana Dinache
“Carol Davila” University of Medicine and Farmacy, Bucharest, Romania
“Dr. Ion Stoia” Clinical Center for Rheumatic Diseases, Bucharest, Romania
Claudiu C. Popescu
claudiu.popescu@reumatologiedrstoia.ro
“Carol Davila” University of Medicine and Farmacy, Bucharest, Romania
“Dr. Ion Stoia” Clinical Center for Rheumatic Diseases, Bucharest, Romania
Corina D. Mogoșan
“Carol Davila” University of Medicine and Farmacy, Bucharest, Romania
“Dr. Ion Stoia” Clinical Center for Rheumatic Diseases, Bucharest, Romania
Cătălin Codreanu
“Carol Davila” University of Medicine and Farmacy, Bucharest, Romania
“Dr. Ion Stoia” Clinical Center for Rheumatic Diseases, Bucharest, Romania
Luminita Enache
“Carol Davila” University of Medicine and Farmacy, Bucharest, Romania
“Dr. Ion Stoia” Clinical Center for Rheumatic Diseases, Bucharest, Romania
Language: English
Submitted on: Feb 24, 2026
Published on: Apr 13, 2026
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Oana-Georgiana Dinache, Claudiu C. Popescu, Corina D. Mogoșan, Cătălin Codreanu, Luminita Enache, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.